Interestingly, here we found that efavirenz and nevirapine were able to halt the expansion and maintenance of CD133+ melanoma cells inducing high levels of apoptosis and were effective to restrain the activation of HERV-K during microenvironmental modification. Here, PROM1 is linked to melanoma.